ALTONA
LIVE

Serial Number

79236843

Owner

altona Diagnostics GmbH

Filing Date

Jan 11, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ALTONA Trademark

Serial Number: 79236843 • Registration: 6121013

ALTONA is a trademark filed by altona Diagnostics GmbH on January 11, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

altona Diagnostics GmbH (6 trademarks)

Mörkenstraße 12

Entity Type: 99

Trademark Details

Filing Date

January 11, 2018

Registration Date

August 11, 2020

Published for Opposition

May 26, 2020

Goods & Services

Scientific apparatus and instruments for laboratory use and for the conducting and evaluation of diagnostic examinations, namely, fluid handling devices used for disposable bioprocessing applications, pipette racks for laboratory use, sensing and signaling devices for measurement and quality control of materials processing by laser; medical laboratory research instruments for DNA analysis and RNA analysis; computers; data processing apparatus and structural and replacement parts thereof; data processors; computer software programs for controlling laboratory equipment for the isolation and purification of nucleic acids; computer hardware and software systems for in vitro diagnostic or scientific research use, namely, electronic systems comprising fluid handlers, plate readers, vial readers, bar code reader, control software, designed for isolation and purification of nucleic acids, set up reaction mixes for polymerase chain reaction (PCR) and PCR thermal cyclers

Pharmaceutical and veterinary preparations, namely, biological substances and chemical preparations used for medical purposes, namely, diagnosing and monitoring infectious diseases; in vitro diagnostic preparations for medical purposes; in vitro diagnostic test reagents and control standards, namely, reference standards in the nature of pure materials being synthetic DNA, all for medical diagnostic use or veterinary use; diagnostic preparations for medical use; diagnostic reagents for use in identifying pathogens for medical use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for medical use; biological preparations for the treatment of cancer; chemical preparation for the diagnosis of pregnancy

Biological preparations for use in sample preparation and pathogen detection other than for medical or veterinary use, namely, biological preparations for use in industry, private and/or federal laboratories and/or science; biological substances and chemical preparations, namely, reagents for isolation and purification of nucleic acids, in vitro diagnostic test reagents, and control standards for scientific and research purposes; diagnostic reagents for use in identifying pathogens for scientific and research use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for scientific and research use; chemical substances for analysis in scientific and laboratory research, other than for medical or veterinary purposes; chemicals for use in industry

Scientific research; scientific and technological services, namely, technical research and scientific research in the field of molecular biology; development of computer hardware and software; consultancy services for scientific purposes, namely, consulting in the fields of biotechnology, laboratory testing, and diagnostics; technological laboratory consultancy services, namely, consulting in the field of laboratory testing, scientific laboratories, and medical laboratories; clinical laboratory services, namely, conducting clinical trials for others; medical laboratory services; medical research; biochemical research and development

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 11, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 27, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 19, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 2, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 2, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 11, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2020 PUBO
NOTIFICATION PROCESSED BY IB
May 22, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 6, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 6, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2020 CNSA
EXPARTE APPEAL TERMINATED
Apr 20, 2020 EXPT
EX PARTE APPEAL-REFUSAL REVERSED
Apr 20, 2020 EXPR
REPLY BRIEF FILED - CHECK TTAB FILES
Feb 6, 2020 RBFT
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Jan 16, 2020 GNSN
EXAMINERS STATEMENT E-MAILED
Jan 16, 2020 GNES
EXAMINERS STATEMENT - COMPLETED
Jan 16, 2020 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 20, 2019 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Sep 16, 2019 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Sep 16, 2019 GECD
ACTION CONTINUING FINAL - COMPLETED
Sep 16, 2019 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2019 CRFA
ASSIGNED TO LIE
Sep 4, 2019 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 28, 2019 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 28, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 28, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 28, 2019 EXAF
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 17, 2019 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 26, 2019 CRCV
FINAL REFUSAL MAILED
Mar 1, 2019 CNFR
FINAL REFUSAL WRITTEN
Feb 28, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2019 TROA
REFUSAL PROCESSED BY IB
Aug 25, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2018 RFCS
REFUSAL PROCESSED BY MPU
Aug 9, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 31, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 27, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 26, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 25, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 24, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 19, 2018 REPR